Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↑ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | 2025 | 15 | $7.56B | $85.69 | +7.25% | — | -23.15% | — | — | 0 |